The relationship between levels of von willebrand factor and mean platelet volume in subjects with isolated impaired fasting glucose

Medical Science Monitor

Volumn 17, Issue 6, 2011, Pages

  Bostan, Feyzi ^a   Coban, Erkan ^a  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Endothelial dysfunction; Impaired fasting glucose; Mean platelet volume; Von willebrand factor

Indexed keywords

GLUCOSE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HUMAN CELL; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MALE; MEAN PLATELET VOLUME; PATIENT SELECTION; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

EID: 79958708030     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881786     Document Type: Article

References (25)

1. Poredos P: Endothelial dysfunction in the pathogenesis of atherosclerosis. Int Angiol, 2002; 21: 109-116
2. Lip GY, Blann AD: Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res, 1997; 34: 255-265
3. Wagner DD: Cell biology of von Willebrand factor. Annu Rev Cell Biol, 1990; 6: 217-46
4. Pearson JD: Markers of endothelial cell perturbation and damage. Br J Rheumatol, 1993; 32: 651-652
5. Blann AD, Taberner DA: A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol, 1995; 90: 244-248
6. Bath PM, Butterworth RJ: Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis, 1996; 7: 157-561
7. Banrroft AJ, Abel EW, Mclaren M, Belch JJ: Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets, 2000; 11: 379-387
8. Endler G, Klimesch A, Sunder-Plassmann H et al: Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol, 2002; 117: 399-404
9. Martin JF, Bath PM, Burr ML: Influence of platelet size on outcome after myocardial infarction. Lancet, 1991; 338: 1409-1411
10. Tschoepe D, Esser J, Schwippert B et al: Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost, 1991; 17: 433-439
11. Ibrahim HA, El-Meligi AA, Abdel Hamid M, Elhendy A: Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus. Med Sci Monit, 2004; 10(3): CR85-CR89
12. Greisenegger S, Endler G, Hsieh K et al: Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke, 2004; 35: 1688-91
13. Coban E, Yazicioglu G, Berkant Avci A, Akcit F: The mean platelet volume in patients with essential and white coat hypertension. Platelets, 2005; 16: 435-438
14. Coban E, Ozdogan M, Yazicioglu G, Akcit F: The mean platelet volume in patients with obesity. Int J Clin Pract, 2005; 59: 981-982
15. Ihara A, Kawamoto T, Matsumoto K et al: Relationship between hemostatic factors and the platelet index in patients with ischemic heart disease. Pathophysiol Haemost Thromb, 2006; 35: 388-391
16. Ihara A, Matsumoto K, Kawamoto T et al: Relationship between hemostatic markers and platelet indices in patients with aortic aneurysm. Pathophysiol Haemost Thromb, 2006; 35: 451-456
17. Coban E, Bostan F: Plasma levels of von Willebrand factor in subjects with isolated impaired fasting glucose. Med Sci Monit, 2009; 15(4): CR194-CR197
18. Bath PM: The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost, 1993; 70: 687-690
19. Kessler L, Wiesel ML, Attali P et al: Von Willebrand factor in diabetic angiopathy. Diabetes Metab, 1998; 24: 327-336
20. Ferreiro JL, Gomez-Hospital JA, Angiolillo DJ: Platelet abnormalities in diabetes mellitus. Diab Vasc Dis Res, 2010; 7(4): 251-259
21. Winocour PD, Watala C, Perry DW: Kinlough-Rathbone RL. Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins. Thromb Haemost, 1992; 68: 577-582
22. Watala C, Golański J, Boncler MA et al: Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood. Platelets, 1998; 9: 315-327
23. Keating FK, Sobel BE, Schneider DJ: Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am J Cardiol, 2003; 92: 1362-1365
24. Assert R, Scherk G, Bumbure A et al: Regulation of protein kinase C by short-term hyperglycaemia in human platelets in vivo and in vitro. Diabetologia, 2001; 44: 188-195
25. Ferretti G, Rabini RA, Bacchetti T et al: Glycated low-density lipoproteins modify platelet properties: a compositional and functional study. J Clin Endocrinol Metab, 2002; 87: 2180-2184